Ping An Health Longevity Centers launch
11 Health Longevity Centers unveiled nationwide, a 46-partner Ecosystem Alliance, and why AI-driven longevity science is moving from research to consumer scale.
Building pharmaceutical superintelligence, from target discovery to the clinic.
Founder of a clinical-stage biotech that brought the first end-to-end generative-AI-designed drug into Phase II trials. Pioneer in AI for drug discovery and longevity research since 2014.
Main channels: Forever.ai and LinkedIn · Contributor to Fortune and Fast Company
11 Health Longevity Centers unveiled nationwide, a 46-partner Ecosystem Alliance, and why AI-driven longevity science is moving from research to consumer scale.
· Taipei
· Washington, DC
· Hong Kong
· Abu Dhabi
· New York
· Virtual
· Boston, MA (Harvard University)
· New York
· Paris
· Las Vegas
· Split, Croatia
· Hong Kong
· London
· London
· San Diego
· Shanghai
· Copenhagen
· London
· Redmond Seattle
· Riyadh
· Park City
· Hong Kong
· Shanghai
· New York
· Shanghai
· Virtual
· Boston
· Singapore
· Singapore
Month-by-month journal, 2023 to 2026
396 peer-reviewed papers · 25.5K citations · h-78
653 public events, 300+ speaking engagements
32 preclinical candidates · 13 INDs · 0 failures
Forever.ai newsletter + Forbes archive
Peakspan, SuperDNA, Longevity Pledge…
"I pledge to dedicate 100% of my professional time and effort to the cause of extending healthy human lifespan through science, technology, and ethical advocacy."
Founded by Alex Zhavoronkov, a public commitment to devote one's career to longevity research and healthspan extension.